Scientists identified a driver of aggressive prostate cancer and a potential way to stop drug-resistant tumors forming.

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

"The number of men living with prostate cancer also continues to rise, so it's vital that we see investment in prostate ...

A veteran's metastatic prostate cancer diagnosis highlights the importance of PSA screening, early detection and informed ...

The American Cancer Society predicts 1 in 8 men will be diagnosed with prostate cancer in their lifetime.

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine ...

Prostate cancer is the most commonly diagnosed cancer in American men — and the second leading cause of cancer-related deaths. One in eight men will be diagnosed in their lifetime. And Black men are ...

Men in England diagnosed with incurable advanced prostate cancer are more likely to survive for at least three years than ...

Men with early-stage prostate cancer can safely hold off on radiation or surgery , confirms a new study that offers the longest-term treatment data yet. "Watchful waiting," more recently renamed ...

Prostate cancer cases are rising in India, but advances in diagnostics, targeted therapies and personalised treatment are ...

VIR-5500 and [²¹²Pb]PSV359 received FDA fast track designations for prostate cancer and solitary fibrous tumors, respectively ...

Bruce Arians shared his prostate cancer survival story during the NFL's "Crucial Catch" week, urging men to get a simple PSA ...